Teprotumumab for the Treatment of Active Thyroid Eye Disease
Original Article
R.S. Douglas, G.J. Kahaly, A. Patel, S. Sile, E.H. Thompson, R. Perdok, J.C. Fleming, B.T. Fowler, C. Marcocci, M. Marinò, A. Antonelli, R. Dailey, G.J. Harris, A. Eckstein, J. Schiffman, R. Tang, C. Nelson, M. Salvi, S. Wester, J.W. Sherman, T. Vescio, R.J. Holt, and T.J. Smith
N Engl J Med 2020;382:341-352
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, January 23, 2022 - 11:59pm.